Literature DB >> 2954962

Inactivation of factor Va by plasmin.

M N Omar, K G Mann.   

Abstract

The inactivation of Factor Va by plasmin was studied in the presence and absence of phospholipid vesicles and calcium ions. The cleavage patterns of bovine Factor Va and its isolated subunits were analyzed using polyacrylamide gel electrophoresis, and the progress of inactivation was monitored by clotting assays and measurements of prothrombin activation using 5-dimethylaminonaphthalene-1-sulfonylarginine-N-(3-ethyl-1,5-penta nediyl)amide. In addition, the ability of prothrombin and Factor Xa to protect Factor Va from inactivation by human plasmin was examined. The data presented indicate that the cofactor Factor Va is inactivated rapidly upon its interaction with human plasmin. The rate of inactivation is significantly enhanced in the presence of phospholipid vesicles, suggesting that the inactivation process is a membrane-bound phenomenon. The isolated D component (heavy chain of factor Va) was found to be slowly degraded by human plasmin, giving rise to cleavage products different from those obtained with activated protein C and Factor Xa. However, the 48- and 30-kDa fragments obtained from human plasmin degradation of component E (light chain of Factor Va) appear to be similar to those obtained following the proteolysis of the same subunit by activated protein C and Factor Xa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954962

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Fibrinolysis and the control of blood coagulation.

Authors:  John C Chapin; Katherine A Hajjar
Journal:  Blood Rev       Date:  2014-09-16       Impact factor: 8.250

Review 2.  Hemorrhagic blood failure: Oxygen debt, coagulopathy, and endothelial damage.

Authors:  Nathan J White; Kevin R Ward; Shibani Pati; Geir Strandenes; Andrew P Cap
Journal:  J Trauma Acute Care Surg       Date:  2017-06       Impact factor: 3.313

3.  Does plasmin have anticoagulant activity?

Authors:  Jane Hoover-Plow
Journal:  Vasc Health Risk Manag       Date:  2010-04-15

4.  Identification of plasmin-interactive sites in the light chain of factor VIII responsible for proteolytic cleavage at Lys36.

Authors:  Keiji Nogami; Katsumi Nishiya; Evgueni L Saenko; Masahiro Takeyama; Kenichi Ogiwara; Akira Yoshioka; Midori Shima
Journal:  J Biol Chem       Date:  2009-01-06       Impact factor: 5.157

5.  Procoagulant and fibrinolytic activity after polytrauma in rat.

Authors:  Xiaowu Wu; Daniel N Darlington; Andrew P Cap
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-02       Impact factor: 3.619

6.  Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency.

Authors:  Joline L Saes; Saskia E M Schols; Kathleen F Betbadal; Mark van Geffen; Kitty Verbeek-Knobbe; Sweta Gupta; Brandon M Hardesty; Amy D Shapiro; Waander L van Heerde
Journal:  Haemophilia       Date:  2019-08-30       Impact factor: 4.287

7.  ptFVa (Pseudonaja Textilis Venom-Derived Factor Va) Retains Structural Integrity Following Proteolysis by Activated Protein C.

Authors:  Mark Schreuder; Xiaosong Liu; Ka Lei Cheung; Pieter H Reitsma; Gerry A F Nicolaes; Mettine H A Bos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-06-24       Impact factor: 8.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.